Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01884389 · ClinicalTrials.gov registry record · Phase 2

Randomized Trial of an HIV Navigation Program for Early Palliative Care

A Phase 2 study, sponsored by Case Western Reserve University.

Completed
Registry status
Phase 2
Development phase
179
Enrollment target

NCT01884389 is a Phase 2 study that has completed, run by Case Western Reserve University. The registered enrollment target is 179 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01884389, a Phase 2 study, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
Phase 2
Development phase
179 participants
Enrollment target

Study Summary

This study is testing a navigation program for early palliative care provided in tandem with HIV primary care for persons living with HIV (PLWH) who are at high risk or mortality and morbidity related to their co-morbid chronic conditions. Participants are enrolled for a period of 36 months, with data collection at enrollment and every 9 months after, for a total of 5 data collection time points. Study participants enrolled will be randomized into one of two groups: control or intervention. Control group participants will receive control calls in between survey data collection time points. Intervention group participants will participate in a Navigation Program which includes home visits and phone calls with an advanced practice nurse (APN) and licensed social worker (LSW), as well as visits / calls by a volunteer if desired. The frequency of visits / calls will be determined based on level of need (high, medium or low). The specific aims of the study are to: 1) identify needs and preferences for palliative care and advance care planning for PLWH, in order to tailor an existing Navigation Program for this study; 2) test the effectiveness of an HIV Navigation Program intervention on outcomes of quality of life, symptom burden, coping ability, and advance care planning; and 3) determine if effectiveness of the HIV Navigation Program intervention differs by age, gender, ethnicity, education, income level, and level of palliative care service need.

Interventions

  • OTHER Patient Navigation

Trial Details

FieldValue
Enrollment Target 179 participants
Start Date 2013-06
Est. Completion 2017-07-31
Phase Phase 2

Sponsor

Case Western Reserve University

141 total trials

What the Registry Record Tells You About NCT01884389

The ClinicalTrials.gov registry entry for NCT01884389 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Patient Navigation is the first listed.

NCT01884389 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01884389 about?

NCT01884389 is a clinical study titled "Randomized Trial of an HIV Navigation Program for Early Palliative Care". This study is testing a navigation program for early palliative care provided in tandem with HIV primary care for persons living with HIV (PLWH) who are at high risk or mortality and morbidity related to their co-morbid chronic conditions. Participants are enrolled for a period of 36 months, with da...

What is the current status of trial NCT01884389?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 179 participants. The study started on 2013-06. Estimated completion is 2017-07-31.

What interventions are being tested in trial NCT01884389?

The interventions under investigation include: Patient Navigation (OTHER).

Who is sponsoring clinical trial NCT01884389?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.